American International Group’s Mustang Bio MBIO Stock Holding History

American International Group’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49	Closed	-$37K	–	3197
2022 Q1	$37K	Sell	49 -3	-6%	-$2.46K	﹤0.01%	2935
2021 Q4	$64K	Buy	52 +1	+2%	+$1.61K	﹤0.01%	2878
2021 Q3	$102K	Sell	51 -1	-2%	-$2.15K	﹤0.01%	2799
2021 Q2	$129	Buy	52 +13	+33%	+$31.9K	﹤0.01%	2770
2021 Q1	$97	Hold	39	–	–	﹤0.01%	2738
2020 Q4	$111	Buy	39 +16	+70%	+$38.2K	﹤0.01%	2600
2020 Q3	$54K	Hold	23	–	–	﹤0.01%	2853
2020 Q2	$56K	Buy	23 +1	+5%	+$2.34K	﹤0.01%	2844
2020 Q1	$44K	Sell	22 -1	-4%	-$2.56K	﹤0.01%	2735
2019 Q4	$71K	Hold	23	–	–	﹤0.01%	2776
2019 Q3	$57K	Sell	23 -1	-4%	-$2.74K	﹤0.01%	2861
2019 Q2	$65K	Buy	24 +10	+71%	+$28.5K	﹤0.01%	2880
2019 Q1	$35K	Hold	14	–	–	﹤0.01%	2945
2018 Q4	$31K	Hold	14	–	–	﹤0.01%	2976
2018 Q3	$64K	Hold	14	–	–	﹤0.01%	3006
2018 Q2	$75K	Buy	+14	New	+$88.4K	﹤0.01%	2896

Other funds holding MBIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

American International Group's MBIO Position: Q2 2022 in Review

American International Group sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 49 shares — an estimated $37K sold.

American International Group first reported a position in MBIO in Q2 2018 and held it in 16 quarters. The position peaked at $102K in Q3 2021. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

American International Group reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
American International Group sold 49 Mustang Bio shares in Q2 2022, an estimated $37K.
American International Group first reported a position in Mustang Bio in Q2 2018 and held it in 16 quarters.
American International Group's Mustang Bio position peaked at $102K in Q3 2021.
71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.